Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Well Well

View:

Post by Red~One on May 27, 2022 12:00pm

Well Well

The Company’s lack of financial resources has also impacted the Company’s research and development activities and has resulted in the Company placing the Phase 1 clinical study of R-107 on hold. The Company will not be able to complete the Annual Documents and Q1 Filings, nor will it be able to re-start the Phase 1 clinical study of R-107, until it raises additional capital.

The Company is seeking to raise additional capital and is working to do so with a U.S. based firm that advises clients on private debt, equity capital and M&A transactions.

183